A study by Peretto et al. showed that immunomodulatory therapy can potentially be used to treat inflammation in cardiomyopathies linked to the DSP (Fig. 2), TTN, FLNC, PKP2, LMNA, and SCN5 A genes. Here, FLNC is linked to cardiomyopathy.